Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106518842A reveals optimized Alectinib route enhancing yield and scalability for pharmaceutical manufacturing supply chains globally.
Patent CN113262822A introduces a robust N-heterocyclic carbene palladium catalyst for efficient adapalene production, offering significant cost reduction in API manufacturing.
Patent CN105906656A reveals flow chemistry route for crizotinib intermediate. Reduces cost and energy significantly. Reliable supplier for pharmaceutical intermediates ensuring high purity.
Patent CN111606791A details a green oxidation method using Fe(III)/NHPI. Offers high purity intermediates for pharma with reduced heavy metal contamination risks.
Patent CN119409702B reveals a safer synthesis route for dipyridamole intermediates. Achieve high purity and supply chain stability with advanced catalytic methods.
Novel large Stokes shift NIR emitter via Suzuki coupling. Ideal for bio-imaging. Reliable supply chain and cost-effective synthesis route available.
Novel synthetic method for Polmacoxib intermediate avoiding cyanide. High purity, scalable process for pharmaceutical supply chains.
Patent CN115850111A details a nickel-catalyzed migration defluorination allylation. This method offers cost reduction in pharmaceutical intermediates manufacturing with high regioselectivity.
Patent CN115536720A details a novel chemical synthesis for cholic acid intermediate A8, offering a virus-free, plant-based alternative to animal extraction with scalable manufacturing potential.
Novel amino acid-catalyzed route in ionic liquids offers green, high-yield production of alpha-acyl substituted esters for pharmaceutical manufacturing.
Patent CN110627783A details a green DES method for carbazole Schiff bases. High yield, recyclable solvent, cost-effective for electronic and pharma intermediates.
Novel synthesis of 4-ethyl-7,8-dihydro-IH-pyrano[3,4-f]indolizine-3,6,10(4H)-trione offering cost reduction and safer scale-up for API manufacturing.
Patent CN104710259A details a novel Ru/C catalyzed amide synthesis using air oxidation, offering high purity and cost reduction for pharmaceutical intermediate manufacturing.
Advanced salifying process for PSDS improves yield and purity. Reduces solvent use and energy consumption for reliable pharmaceutical intermediates supply chain.
Novel urea compound synthesis patent CN105820085A offers stable pharmaceutical intermediates for type II diabetes research with optimized sulfonylation processes reducing manufacturing complexity.
Patent CN119977968A reveals a novel synthesis route for 2-amino-6-chloropurine with high yield and reduced wastewater, offering significant supply chain advantages.
Patent CN111732594A reveals a cost-effective 3-step route for Fluzoparib, eliminating Pd/C hydrogenation and expensive coupling reagents for scalable manufacturing.
Patent CN111217848A details novel silicon-centered spiro ligands enabling high-yield asymmetric synthesis. Discover supply chain advantages and cost reduction in pharmaceutical intermediate manufacturing.
Novel coupled melt crystallization patent achieves 99.95% purity without solvents. Significant cost reduction and supply chain reliability for fine chemical intermediates manufacturing globally.
Patent CN114805152B reveals a mild nitronium salt-promoted method for thioamides, offering cost reduction in API manufacturing and scalable routes for complex intermediates.